Abstract | OBJECTIVE: METHODS: Synovial fibroblasts were collected from 5 cases of rheumatoid arthritis. Peripheral blood mononuclear cells (PBMCs) were obtained from 5 healthy people by Ficoll- Hypaque density gradien centrifugation. The cells were stimulated with IL-1beta, TNF-alpha, IL-17 and other cytokines, and then the expression of CCL19 was detected by RT-PCR. The cells also were treated with different concentration of CCL19, then the expressions of IL-1beta, TNF-alpha were detected by RT-PCR, the expressions of p-ERK, p-p38 were detected by western blot. RESULTS: IL-1beta promoted the CCL19/CCR7 expression in both synovial fibroblasts and PBMCs. CCL19 upregulated the expression of IL-10 in both synovial fibroblasts and PBMCs. The stimulation of CCL19 also increased its receptor CCR7 expression. CCL19 activated p-ERK and p-p38 in PBMCs. CONCLUSION:
|
Authors | Lian-jie Shi, Jian-hong Li, Xiao-min Cen, Nan-ping Yang, Geng Yin, Qi-bing Xie |
Journal | Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition
(Sichuan Da Xue Xue Bao Yi Xue Ban)
Vol. 46
Issue 2
Pg. 272-5
(Mar 2015)
ISSN: 1672-173X [Print] China |
PMID | 25924444
(Publication Type: Journal Article)
|
Chemical References |
- CCL19 protein, human
- Chemokine CCL19
- IL10 protein, human
- Interleukin-17
- Interleukin-1beta
- Tumor Necrosis Factor-alpha
- Interleukin-10
|
Topics |
- Arthritis, Rheumatoid
(physiopathology)
- Cells, Cultured
- Chemokine CCL19
(metabolism)
- Fibroblasts
(metabolism)
- Humans
- Inflammation
(physiopathology)
- Interleukin-10
(metabolism)
- Interleukin-17
(pharmacology)
- Interleukin-1beta
(pharmacology)
- Leukocytes, Mononuclear
(metabolism)
- MAP Kinase Signaling System
- Synovial Membrane
(cytology)
- Tumor Necrosis Factor-alpha
(pharmacology)
|